These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34418726)

  • 1. Comparison between
    Nava-Cabrera M; Azorín-Vega E; Oros-Pantoja R; Aranda-Lara L
    Appl Radiat Isot; 2021 Oct; 176():109898. PubMed ID: 34418726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the radiation absorbed dose produced by
    Azorín-Vega E; Rojas-Calderón E; Ferro-Flores G; Aranda-Lara L; Jiménez-Mancilla N; Nava-Cabrera MA
    Appl Radiat Isot; 2019 Apr; 146():66-71. PubMed ID: 30753987
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Santos-Cuevas C; Ferro-Flores G; García-Pérez FO; Jiménez-Mancilla N; Ramírez-Nava G; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Davanzo J; Soldevilla-Gallardo I
    Contrast Media Mol Imaging; 2018; 2018():5247153. PubMed ID: 30534027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical dosimetric studies of
    Meléndez-Alafort L; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Turato S; Fracasso G; Bolzati C; Rosato A; De Nardo L
    Med Phys; 2021 Jul; 48(7):4064-4074. PubMed ID: 33966284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
    Ruigrok EAM; Tamborino G; de Blois E; Roobol SJ; Verkaik N; De Saint-Hubert M; Konijnenberg MW; van Weerden WM; de Jong M; Nonnekens J
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3627-3638. PubMed ID: 35556158
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ocampo-García B; Cruz-Nova P; Jiménez-Mancilla N; Luna-Gutiérrez M; Oros-Pantoja R; Lara-Almazán N; Pérez-Velasco D; Santos-Cuevas C; Ferro-Flores G
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining Absorbed Doses of Indigenously Developed
    Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
    Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
    [No Abstract]   [Full Text] [Related]  

  • 8. Tandem Isotope Therapy with
    Meyer C; Stuparu A; Lueckerath K; Calais J; Czernin J; Slavik R; Dahlbom M
    J Nucl Med; 2023 Nov; 64(11):1772-1778. PubMed ID: 37797974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403.
    Ling X; Latoche JD; Choy CJ; Kurland BF; Laymon CM; Wu Y; Salamacha N; Shen D; Geruntho JJ; Rigatti LH; Windish HP; Langton-Webster B; Berkman CE; Anderson CJ
    Mol Imaging Biol; 2020 Apr; 22(2):274-284. PubMed ID: 31321650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
    Feuerecker B; Tauber R; Knorr K; Heck M; Beheshti A; Seidl C; Bruchertseifer F; Pickhard A; Gafita A; Kratochwil C; Retz M; Gschwend JE; Weber WA; D'Alessandria C; Morgenstern A; Eiber M
    Eur Urol; 2021 Mar; 79(3):343-350. PubMed ID: 33293081
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kristiansson A; Örbom A; Ahlstedt J; Karlsson H; Zedan W; Gram M; Åkerström B; Strand SE; Altai M; Strand J; Vilhelmsson Timmermand O
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33579037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Intrapatient Dosimetry Comparison of
    Rinscheid A; Gäble A; Wienand G; Pfob C; Dierks A; Kircher M; Trepel M; Weckermann D; Lapa C; Bundschuh RA
    J Nucl Med; 2023 Dec; 64(12):1918-1924. PubMed ID: 37770108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated
    Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS
    Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity Assessment of [
    Hernández-Jiménez T; Cruz-Nova P; Ancira-Cortez A; Gibbens-Bandala B; Lara-Almazán N; Ocampo-García B; Santos-Cuevas C; Morales-Avila E; Ferro-Flores G
    Nanomaterials (Basel); 2022 Nov; 12(23):. PubMed ID: 36500804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Dosimetry in
    Jackson PA; Hofman MS; Hicks RJ; Scalzo M; Violet J
    J Nucl Med; 2020 Jul; 61(7):1030-1036. PubMed ID: 31806772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical efficacy of hK2 targeted [
    Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
    Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Santos-Cuevas C; Davanzo J; Ferro-Flores G; García-Pérez FO; Ocampo-García B; Ignacio-Alvarez E; Gómez-Argumosa E; Pedraza-López M
    Nucl Med Biol; 2017 Sep; 52():1-6. PubMed ID: 28575794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specific Membrane Antigen Radioligand Therapy Using
    Schuchardt C; Zhang J; Kulkarni HR; Chen X; Müller D; Baum RP
    J Nucl Med; 2022 Aug; 63(8):1199-1207. PubMed ID: 34887335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.